GSK plc - 07 Dec 2023 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
10%+ Owner
Signature
/s/ Victoria Whyte, Authorized Signatory, GSK plc
Issuer symbol
WVE
Transactions as of
07 Dec 2023
Net transactions value
+$16,500,000
Form type
4
Filing time
30 Jan 2024, 16:39:08 UTC
Previous filing
30 Jan 2023
Next filing
01 Oct 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Purchase $16,500,000 +3,300,000 +31% $5.00 13,983,761 07 Dec 2023 By Corporation F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").